Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Curr Pharm Des. 2016;22(14):2152–2159. doi: 10.2174/1381612822666160127114237

Figure 3.

Figure 3

α7 nAChR and lung cancer cell growth. A. The α7 nAChR antagonist methyllycaconitine (MLA) has no effect on cell growth of A549 lung adenocarcinoma cells. Similar results were seen with α-bungarotoxin and in the H82 and H520 cell lines (data not shown). B. siRNA knockdown of α7 decreases cell growth in H520 squamous cell lung carcinoma cells compared to cells transfected with control siRNA. C. siRNA knockdown of α7 decreases cell growth in A549 lung adenocarcinoma cells compared to cells transfected with control siRNA.